Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis

Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis

Platinum-based chemotherapy is the de facto standard treatment for metastatic or unresectable thymic carcinoma. The optimal chemotherapy regimen has not yet been determined, including whether this should be combined with a second- or third-generation anti-cancer agent. We retrospectively evaluated t...

Full description

Bibliographic Details
Main Authors: Akito Fukuda, Yusuke Okuma, Taiki Hakozaki, Kie Mirokuji, Makiko Yomota, Tsunekazu Hishima, Yukio Hosomi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
thymic carcinoma
cisplatin
irinotecan
first-line chemotherapy
metastasis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.779700/full

Similar Items

Similar Items